Comparing domestic and imported hearing aids for age-related hearing loss
Official title: A Non-Inferiority, Single-Blind, Randomized Controlled Trial Comparing the Efficacy of Domestic Versus Imported Hearing Aids in Patients With Moderate to Severe and Severe Age-Related Hearing Loss
Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06882889 · Data updated 2026-11-12
This study is testing whether hearing aids made in the U.S. work better than imported ones for older adults with age-related hearing loss.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 85 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | October 24, 2024 |
| Main results expected | August 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT06882889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Chinese individuals aged 60 to 85 with moderate to severe age-related sensorineural hearing loss.
✕Probably not a fit
Patients with noise-induced, hereditary, or drug-induced hearing loss, or those unable to use hearing aids will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness of domestic hearing aids from the Bigsound brand with imported hearing aids from the Phonak brand in patients aged 60 to 85 with moderate to severe age-related hearing loss. Eighty participants will be randomly assigned to either group and will undergo a 30-minute trial with their respective hearing aids. Hearing improvements will be measured using Pure Tone Average (PTA) and Speech Recognition Threshold (SRT) before and after the trial, and a cost-effectiveness analysis will be conducted based on the market prices and hearing improvements. Additionally, patient-reported outcomes will be assessed using standardized questionnaires.
Why it matters
Potential benefit: If successful, this study could help patients make informed choices about hearing aids based on their effectiveness and cost.
How similar studies have gone: Previous studies have shown varying results in comparing different hearing aid brands, but this specific comparison is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 60 years and ≤ 85 years; 2. Diagnosed with age-related hearing Loss, which is characterized by bilateral, symmetrical, and gradually progressive hearing loss primarily affecting high frequencies, along with a decline in speech recognition ability, as referenced in the "Expert Consensus on Diagnosis and Intervention of Age-Related Hearing Loss" (2019 edition); 3. Age-related hearing Loss is of moderate to severe or severe sensorineural hearing loss, with moderate to severe defined as 50 to \<65 dB HL, and severe defined as 65 to \<80 dB HL; 4. Chinese nationality, able to complete all assessments in the Chinese language; 5. Right-handed; 6. No significant neurological diseases, severe systemic diseases, family history of genetic disorders, or major psychiatric conditions; Exclusion Criteria: 1. Exclusion of noise-induced hearing loss, hereditary hearing loss, drug-induced hearing loss, etc.; 2. Inability to use hearing aids ; 3. Presence of dementia, Parkinson's disease, or other neurodegenerative diseases that may affect study compliance; 4. History of cerebrovascular accidents, stroke, epilepsy, or other central nervous system disorders; 5. Other conditions deemed by the investigator to be exclusionary.
Where it's running
-
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Yang Haidi, PhD
- Email: yanghaidi1978@163.com
- Phone: 13178821663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating cognitive function changes in older adults with hearing loss using hearing aids
This study is testing if using hearing aids can help older adults with hearing loss think better and lower their chances of developing dementia.
-
DX243: a near-term test for safety and tolerability in adults with age-related hearing loss
We are testing DX243 to see if it is safe and tolerable in adults with mild-to-moderate age-related hearing loss while also looking for early signs it might help with hearing.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Gene therapy for hearing loss caused by OTOF gene mutations
This study is testing a new gene therapy to see if it can help children with hearing loss caused by OTOF gene mutations hear better.
-
Using robotics and electrocochleography for cochlear implant surgery
This study is testing if using a robotic system during cochlear implant surgery can help improve outcomes for people with hearing loss.
-
Understanding listening effort in cochlear implant users
This study tests how much effort people with cochlear implants need to understand speech compared to those with normal hearing, using speech tests and measuring pupil size to see how hard they are working to listen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.